< Back to companies
FOXO Technologies

FOXO Technologies

Houston, Texas, United States

FOXO is a biotechnology company dedicated to improving human health and longevity through the development of cutting-edge technology and product solutions for various industries, including life insurance. FOXO’s epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. FOXO is committed to leveraging the latest advancements in science and technology to help people live better, longer lives. FOXO also owns Myrtle Recovery Centers, Inc., a 30 bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
www.foxotechnologies.com/

Categories

AI / MLPrecision Medicine/Diagnostics

Disease Areas

Technologies

EpigeneticsMachine LearningBiomarkers
Only accessible to MedStartr community members. Join now

What do you think of FOXO Technologies?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now